The 6th Congress — Tarragona 1968

Abstract

In 1968, at the time of the 6th CINP Congress, psychopharmacology seemed to have a promising, optimistic future. A series of discoveries during the 1950s had focused attention on the psychoactive properties of drugs. Interest in psychopharmacology was stimulated by the identification of hallucinogenic drugs and the discovery of LSD-25, which according to many authors could induce symptoms resembling those seen in severe psychosis. Also, the recognition of the antipsychotic effect of phenothiazines gave rise to the belief that time had come when both the causes and the specific treatments for the different mental illnesses could be revealed.